These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34567166)

  • 1. HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.
    Mahboubi-Rabbani M; Abbasi M; Hajimahdi Z; Zarghi A
    Iran J Pharm Res; 2021; 20(2):333-369. PubMed ID: 34567166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
    Gill MSA; Hassan SS; Ahemad N
    Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibitor design for HIV-1 reverse transcriptase and integrase enzymes: a molecular docking study.
    Ercan S; Şenyiğit B; Şenses Y
    J Biomol Struct Dyn; 2020 Feb; 38(2):573-580. PubMed ID: 31787027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designed multiple ligands: an emerging anti-HIV drug discovery paradigm.
    Zhan P; Liu X
    Curr Pharm Des; 2009; 15(16):1893-917. PubMed ID: 19519431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
    Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
    Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
    Wang Z; Vince R
    Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication.
    Esposito F; Carli I; Del Vecchio C; Xu L; Corona A; Grandi N; Piano D; Maccioni E; Distinto S; Parolin C; Tramontano E
    Phytomedicine; 2016 Nov; 23(12):1383-1391. PubMed ID: 27765358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress of dual inhibitors targeting HIV-1 reverse transcriptase and integrase].
    Liu H; Zhan P; Liu XY
    Yao Xue Xue Bao; 2013 Apr; 48(4):466-76. PubMed ID: 23833931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drug targets for antiretroviral therapy.
    Reeves JD; Piefer AJ
    Drugs; 2005; 65(13):1747-66. PubMed ID: 16114975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment Based Strategies for Discovery of Novel HIV-1 Reverse Transcriptase and Integrase Inhibitors.
    Latham CF; La J; Tinetti RN; Chalmers DK; Tachedjian G
    Curr Top Med Chem; 2016; 16(10):1135-53. PubMed ID: 26324045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors.
    Koneru PC; Francis AC; Deng N; Rebensburg SV; Hoyte AC; Lindenberger J; Adu-Ampratwum D; Larue RC; Wempe MF; Engelman AN; Lyumkis D; Fuchs JR; Levy RM; Melikyan GB; Kvaratskhelia M
    Elife; 2019 May; 8():. PubMed ID: 31120420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase.
    Choi E; Mallareddy JR; Lu D; Kolluru S
    Future Sci OA; 2018 Oct; 4(9):FSO338. PubMed ID: 30416746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in antiretroviral therapy in HIV infection.
    Arora DR; Gautam V; Gill PS; Mishra N
    J Indian Med Assoc; 2010 Jan; 108(1):29-34. PubMed ID: 20839577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptide inhibitors of HIV transmission.
    Shi S; Nguyen PK; Cabral HJ; Diez-Barroso R; Derry PJ; Kanahara SM; Kumar VA
    Bioact Mater; 2016 Dec; 1(2):109-121. PubMed ID: 29744399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel inhibitors of HIV-1 integration.
    Witvrouw M; Van Maele B; Vercammen J; Hantson A; Engelborghs Y; De Clercq E; Pannecouque C; Debyser Z
    Curr Drug Metab; 2004 Aug; 5(4):291-304. PubMed ID: 15320701
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.